Phytomedical gains $10m for diabetes, cachexia research
Canadian biopharmaceutical company PhytoMedical has entered into an agreement with Fusion Capital Fund II to raise up to $10 million in equity financing for its research programs, including investigations into cinnamon compounds, writes Jess Halliday.